Rchr
J-GLOBAL ID:201801007103478360   Update date: Mar. 10, 2024

Yuki Toda

Yuki Toda
Research field  (2): Hematology and oncology ,  Pharmaceuticals - health and biochemistry
Research keywords  (3): がん転移 ,  がん微小環境 ,  低酸素
Research theme for competitive and other funds  (2):
  • 2020 - 2023 Hypoxic adaptation of myeloma stem cells by secreting miRNA throuhg exosomes
  • 2019 - 2022 Development of exosome-capturing antibody-conjugated nucleic acid medicines against multiple myeloma
Papers (21):
  • Daiki Shimizu, Miku Ishibashi, Tadaaki Yamada, Yuki Toda, Shigekuni Hosogi, Eishi Ashihara. POLD1 Is Required for Cell Cycle Progression by Overcoming DNA Damage in Malignant Pleural Mesothelioma. Cancer genomics & proteomics. 2024. 21. 2. 158-165
  • Yusuke Sano, Naoko Kuwabara, Saori Nakagawa, Yuki Toda, Shigekuni Hosogi, Shinji Sato, Eishi Ashihara. Hypoxia-adapted Multiple Myeloma Stem Cells Resist γδ-T-Cell-mediated Killing by Modulating the Mevalonate Pathway. Anticancer research. 2023. 43. 2. 547-555
  • Yuki Sugiyama, Seikou Nakamura, Yuichi Tokuda, Masakazu Nakano, Yasunao Hattori, Hiroki Nishiguchi, Yuki Toda, Shigekuni Hosogi, Masayuki Yamashita, Kei Tashiro, et al. 7,8-Dihydroxy-3-(4′-hydroxyphenyl)coumarin inhibits invasion and migration of osteosarcoma cells. Biochemical and Biophysical Research Communications. 2023. 638. 200-209
  • Emi Soma, Asako Yamayoshi, Yuki Toda, Yuji Mishima, Shigekuni Hosogi, Eishi Ashihara. Successful Incorporation of Exosome-Capturing Antibody-siRNA Complexes into Multiple Myeloma Cells and Suppression of Targeted mRNA Transcripts. Cancers. 2022. 14. 3. 566-566
  • Mako Tomogane, Maho Omura, Yusuke Sano, Daiki Shimizu, Yuki Toda, Shigekuni Hosogi, Shinya Kimura, Eishi Ashihara. Expression level of BTN3A1 on the surface of CD14+ monocytes is a potential predictor of γδ T cell expansion efficiency. Biochemical and biophysical research communications. 2022. 588. 47-54
more...
MISC (2):
  • 芦原 英司, 今吉 菜月, Yoshioka Makoto, 中田 晋, Chauhan Jay, 戸田 侑紀, Fletcher Steven, Strovel Jeffrey, 高田 和幸. 新規治療薬 基礎 新規ブロモドメイン阻害剤CG13250の多発性骨髄腫に対する抗腫瘍効果. International Journal of Myeloma. 2017. 7. 1. 41-41
  • Natsuki Imayoshi, Makoto Yoshioka, Susumu Nakata, Jay Chauhan, Yoko Kado, Yuki Toda, Steven Fletcher, Jeffrey Strovel, Kazuyuki Takata, Eishi Ashihara. A Novel BRD4 Inhibitor CA2 Suppresses MM Cell Proliferation in an Orthotopic Myeloma Mouse Model. BLOOD. 2016. 128. 22
Awards (1):
  • 2019/05 - 第44回日本骨髄腫学会学術集会優秀ポスター賞
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page